lacosamide oral solution

Generic: lacosamide oral

Labeler: florida pharmaceutical products, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lacosamide oral solution
Generic Name lacosamide oral
Labeler florida pharmaceutical products, llc
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

lacosamide 10 mg/mL

Manufacturer
Florida Pharmaceutical Products, LLC

Identifiers & Regulatory

Product NDC 71921-411
Product ID 71921-411_ceee316d-6ad9-4bca-9416-47ae954d174f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA220386
DEA Schedule cv
Listing Expiration 2027-12-31
Marketing Start 2026-01-30

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71921411
Hyphenated Format 71921-411

Supplemental Identifiers

RxCUI
993856
UPC
0371921411719
UNII
563KS2PQY5
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lacosamide oral solution (source: ndc)
Generic Name lacosamide oral (source: ndc)
Application Number ANDA220386 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (71921-411-71) / 200 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

lacosamide (10 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ceee316d-6ad9-4bca-9416-47ae954d174f", "openfda": {"nui": ["N0000008486"], "upc": ["0371921411719"], "unii": ["563KS2PQY5"], "rxcui": ["993856"], "spl_set_id": ["ba4e2e28-7dc3-47b3-9c2c-34e0b1f39fb8"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (71921-411-71)  / 200 mL in 1 BOTTLE", "package_ndc": "71921-411-71", "marketing_start_date": "20260130"}], "brand_name": "Lacosamide Oral Solution", "product_id": "71921-411_ceee316d-6ad9-4bca-9416-47ae954d174f", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71921-411", "dea_schedule": "CV", "generic_name": "Lacosamide Oral", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide Oral Solution", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "10 mg/mL"}], "application_number": "ANDA220386", "marketing_category": "ANDA", "marketing_start_date": "20260130", "listing_expiration_date": "20271231"}